Durgical
EN
Open the app

Sex and gender differences in health and disease

  • Concept

Women and men differ in how some diseases start, show and respond to drugs. Ignoring it has meant missed heart attacks and more drug side effects in women.

Updated

What it is

Sex is biological: chromosomes, gonads, hormones and anatomy. Gender is social: the roles, norms and power that shape behaviour, exposures and access to care. Both change risk, presentation, diagnosis, response to treatment and outcome, and research that studied mostly men has left gaps that still affect care.

Key facts

  • Female cells silence one X chromosome at random, but some X-linked genes escape and are expressed more in women, immune genes among them.
  • Women of reproductive age develop higher antibody titres after vaccination.
  • Coronary microvascular dysfunction (ischaemia without obstructive coronary disease) is more common in women; heart failure with preserved ejection fraction is about twice as common in women.
  • Women often underestimate their cardiovascular risk and seek care later than men.
  • Depression is about twice as common in women; men's presentations, such as irritability or substance use, fit the diagnostic criteria poorly.
  • Osteoporosis is under-diagnosed in men, partly because bone-density norms were built on women; COPD in women is often misdiagnosed.
  • Of 86 drugs with sex differences in kinetics, 76 (88 %) reached higher levels or cleared more slowly in women; when levels were higher in women, 96 % had more adverse reactions in women.
  • A US government review found that 8 of 10 drugs withdrawn in 1997–2000 posed greater risks for women; zolpidem received sex-specific dosing advice only after years of reports of impairment in women.
  • COVID-19 was 1.5 to 2 times more severe in men (hospital and intensive care admission, intubation and death).

Worked example

  1. Made-up trial of a new heart drug: 800 men and 200 women; overall adverse-event rate 10 %.
  2. Analysed by sex: men 64 / 800 = 8 %; women 36 / 200 = 18 %.
  3. Pooled: (64 + 36) / 1,000 = 10 %. The single figure hides a risk in women more than twice that in men.
  4. Risk ratio, women vs men: 18 % / 8 % = 2.25. Sex modifies the effect, so one pooled estimate misleads both groups.
  5. With only 200 women the estimate for women is imprecise: the trial was not designed to answer the question for them.
  6. Reading: enrol both sexes, pre-specify results by sex, then ask whether the cause is biological (kinetics, body size) or social (access, adherence).

Sex, gender or both: classic examples

ExampleSex (biology)Gender (social)What to do
Myocardial infarction in womenMore microvascular dysfunction; ischaemia without obstructive diseaseRisk underestimated, later care-seeking, less reperfusionSame urgent pathway and treatment criteria as for men
Autoimmune diseaseAbout 80 % female; X-linked immune genes, hormonesLittle; the excess is mainly biologicalKeep autoimmunity in the differential in women
Adverse drug reactionsHigher levels and slower clearance in womenDoses studied in men; women under-enrolled in trialsFollow sex-specific label advice; report reactions
DepressionAbout twice as common in womenMen's symptoms (irritability, substance use) missedAsk men about those symptoms too
Osteoporosis in menLower but real riskNorms and screening built for womenConsider it in men with risk factors or fractures

In practice

  • A woman with possible acute coronary syndrome gets the same urgent pathway as a man: electrocardiogram, troponin and the same criteria for reperfusion.
  • When a drug label gives sex-specific advice, follow it, and report suspected adverse reactions.
  • Ask about the social side: who looks after the family, whether she can leave work, whether he avoids doctors. Gender shapes when patients arrive.
  • Reading a trial, ask how many women were enrolled and whether results are shown by sex.

Common pitfalls

  • Using «sex» and «gender» as synonyms in a record or a paper.
  • Pooling men and women and applying the result to both without checking for a difference.
  • Explaining every difference by hormones when access to care also differs.

Common traps

  • Heart disease is a men's disease: in Colombians aged 60 and over ischaemic heart disease is the first cause of death in both sexes, and women receive less timely diagnosis and treatment
  • Sex and gender are synonyms: sex is biology; gender is roles, norms and power, and either can explain a difference
  • A drug tested mostly in men acts the same in women: women often reach higher levels and have nearly twice the adverse reactions
  • Women's autoimmunity is only about hormones: X-linked immune genes that escape inactivation also contribute
  • Depression is mainly a women's disease: it is about twice as common in women, but criteria built on typical symptoms miss many men

Test yourself

Think of the answer, then tap the question to see it.

A trial enrols 85 % men and reports only pooled results. Why is it a problem to apply its safety results to women?

Sex can modify the effect: women may reach higher drug levels and have more adverse reactions, and a pooled figure dominated by men hides that.

A woman with chest pain arrives later than men and is reperfused less often. Is this a sex or a gender difference?

Mainly gender: risk underestimation, later care-seeking and less treatment are social. The answer is the same urgent pathway for everyone.

Why are autoimmune diseases more common in women?

Partly because some X-linked immune genes, such as TLR7, escape X inactivation and are expressed more in women, with hormonal effects added.

Why might osteoporosis be missed in a 70-year-old man?

Screening habits and bone-density norms were built around women, so men are less often tested even though their risk is real.

Most drugs with sex differences in kinetics reach higher blood levels in women. What does that predict?

More adverse drug reactions in women when everyone receives the same dose, which is what a review of 86 such drugs found.

Add to my cards (5)

Elsewhere in DurgiPedia

Connections

← All of epidemiology

Educational content on epidemiological and statistical methods; the examples use made-up numbers to teach the calculation. Not a clinical or legal guide: current Colombian rules are in the official sources.

Sources: Sex and gender: modifiers of health, disease, and medicine (Mauvais-Jarvis F et al., Lancet) (Europe PMC, 2020); Sex differences in pharmacokinetics predict adverse drug reactions in women (Zucker I, Prendergast BJ, Biol Sex Differ) (Europe PMC, 2020); Boletín técnico Estadísticas Vitales (EEVV): nacimientos y defunciones no fetales, año acumulado 2025pr (Departamento Administrativo Nacional de Estadística (DANE), Colombia, 2026).

Spotted a mistake?We are always improving for the community. Tell us what is wrong and our team will review it.Report a mistake

Representative model, for educational purposes only.